SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: john jansen who wrote (1633)1/12/1998 10:11:00 AM
From: Mama Bear  Read Replies (1) of 7041
 
I dunno. perhaps it means that ZONA management isn't above fibbing? If the plaintiff's charge is true of course?

>>>The lawsuit shows that Zonagen filed a patent application for a product it called ImmuMAX knowing that it was actually a common compound called Chitosan and that two U.S. patents already existed for the same use.<<<

I guess the question it raises is that if they were willing to do it there they might have done it again with their patent application for Vasomax.

Also, rarely is there only one cockraoch in the cubboard. If you see one, you can be fairly sure you'll find more.

Just my thoughts.

Barb
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext